Skip to main content
Equibles

KNE · Kane Biotech Inc. · Financials

Use KNE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KNE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.03 CAD -0.01 (-25.00%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked
Market Cap
6.15M CAD
Shares
205.06M
Volume · Nov 6 112K Avg daily vol (3M) 119.3K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
148.98K -4.9%
FY2023 Revenue FY2022–FY2023
Net Income
-5.03M -29.4%
FY2023 Net Income FY2022–FY2023
Gross Margin
73.48% +2pp
FY2023 Gross Margin FY2022–FY2023

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2023 FY2022
CAD 148.98K 156.73K
CAD 109.47K 112.03K
CAD -5.03M -3.89M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.